⌘K
Loading ticker…
As of 2026-08-24, Medicinova, Inc. (MNOV) has a 3-month relative strength percentile of 65 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.7%, relative volume 3.55×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
MNOV is in a stage 1 base, week 10. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 13.6% / 7.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
MNOV appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $837K notional.
Held by 2 ETFs · $972K across latest filings · largest weight 0.01% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $837K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MNOV Jan avg: 9.04% median: 5.44% win: 50% σ: 18.22% n: 4 2022-04-12 → 2026-07-31 | MNOV Feb avg: -11.27% median: -11.82% win: 0% σ: 6.18% n: 4 2022-04-12 → 2026-07-31 | MNOV Mar avg: -2.73% median: -3.67% win: 25% σ: 7.73% n: 4 2022-04-12 → 2026-07-31 | MNOV Apr avg: -3.76% median: -2.31% win: 40% σ: 7.01% n: 5 2022-04-12 → 2026-07-31 | MNOV May avg: -2.48% median: -2.16% win: 40% σ: 6.34% n: 5 2022-04-12 → 2026-07-31 | MNOV Jun avg: 1.66% median: 4.12% win: 60% σ: 5.66% n: 5 2022-04-12 → 2026-07-31 | MNOV Jul avg: -2.05% median: 0.76% win: 60% σ: 5.40% n: 5 2022-04-12 → 2026-07-31 | MNOV Aug avg: 1.38% median: 0.69% win: 50% σ: 8.23% n: 4 2022-04-12 → 2026-07-31 (current) | MNOV Sep avg: 6.12% median: -0.59% win: 50% σ: 23.59% n: 4 2022-04-12 → 2026-07-31 | MNOV Oct avg: -0.97% median: -7.30% win: 25% σ: 21.98% n: 4 2022-04-12 → 2026-07-31 | MNOV Nov avg: 8.69% median: 8.99% win: 50% σ: 20.73% n: 4 2022-04-12 → 2026-07-31 | MNOV Dec avg: -11.92% median: -13.39% win: 25% σ: 10.32% n: 4 2022-04-12 → 2026-07-31 |